Vasoprotective Actions of the Atrial Natriuretic Peptide

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 1, 2005-01 ,pp. : 11-21

Bentham Science Publishers

Access to resources Recommend Favorite

Anterior Hypothalamic Norepinephrine, Atrial Natriuretic Peptide, and Hypertension

By Oparil S.   Chen Y.F.   Peng N.   Wyss J.M.  

Frontiers in Neuroendocrinology, Vol. 17, Iss. 2, 1996-04 ,pp. : 212-246

Academic Press

Access to resources Recommend Favorite

Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis

By Dimitroulas Theodoros   Giannakoulas Georgios   Papadopoulou Klio   Sfetsios Tilemahos   Karvounis Haralambos   Dimitroula Hariklia   Parcharidou Despina   Koliakos Georgios   Garyfallos Alexandros   Styliadis Ioannis   Settas Loukas  

Clinical Rheumatology, Vol. 29, Iss. 9, 2010-09 ,pp. : 957-964

Springer Publishing Company

Access to resources Recommend Favorite

Increased Arterial Compliance in Cirrhosis is Related to Decreased Arterial C-type Natriuretic Peptide, but not to Atrial Natriuretic Peptide

By Henriksen J. H.   Gülberg V.   Gerbes A. L.   Bendtsen F.   Møller S.  

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 5, 2003-01 ,pp. : 559-564

Informa Healthcare

Access to resources Recommend Favorite

Atrial natriuretic peptide (ANP) preconditioning: what is the relevance of the antiapoptotic effects?

By Gugenheim J.  

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 428-430

Elsevier

Access to resources Recommend Favorite